Gene Therapy Media Market Size Worth USD 2,001.61 Million by 2034 | CAGR: 17.27%

The gene therapy media market size is expected to reach USD 2,001.61 million by 2034, according to a new study by Polaris Market Research. The report “Gene Therapy Media Market Share, Size, Trends, Industry Analysis Report: By Product, By Vector Type, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gene therapy media market offers solutions for supporting viral and non-viral vector production, cell culture, and gene therapy manufacturing, including specialty media, serum-free media, and classical media for optimized cell growth, transfection efficiency and reproducible therapeutic outcomes.   

Request a free sample copy or read the full market insights - gene therapy media market Report

Market growth is driven by rising demand for gene therapies in rare and chronic diseases. In addition, expansion of cell and gene therapy manufacturing facilities and adoption of scalable, high-quality media solutions are enhancing vector production efficiency and overall treatment effectiveness.

Gene Therapy Media Market Report Highlights

• Based on product, specialty media dominated in 2024 due to high adoption in viral and non-viral vector production.
• In terms of vector type, AAV production dominated in 2024, driven by widespread application in rare and chronic disease therapies.
• Based on end user, pharmaceutical and biotechnology companies dominated in 2024 due to large-scale manufacturing and high R&D investments.
• North America dominated the global market in 2024, fueled by advanced gene therapy infrastructure and high R&D investment.
• Asia Pacific is projected to record the fastest growth, driven by expanding manufacturing facilities and growing awareness of gene therapies.
• Key players in the global market include FUJIFILM Biosciences, Lonza Group AG, IQVIA Inc., Novartis AG, Nucleus Biologics, Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Amsbio, Cencora, Inc., ElevateBio, Bayer AG, and AstraZeneca.

Polaris Market Research has segmented the market report based on product, vector type, end user, and region:

By Product (Revenue, USD Million, 2020–2034)

• Specialty Media
• Serum-free Media
• Classical Media
• Other Products

By Vector Type (Revenue, USD Million, 2020–2034)

• AAV Production
• LV Production
• Other Vectors

By End User (Revenue, USD Million, 2020–2034)

• Pharmaceutical and Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs) & CROs
• Research and Academic Institutes

By Region (Revenue, USD Million, 2020–2034)

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
  • Latin America
• Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of South Africa